Skip to main content
. 2022 Apr 4;17:65. doi: 10.1186/s13019-022-01812-y

Table 5.

Different trials of Xience DES

Trial Name Stents Duration Stent Thrombosis Rate (%) Reference
ABSIRB II

BVS vs. Xience

(n = 501)

4 years 2.8 vs. 0 [41]
ABSORB China

BVS vs Xience

(n = 480)

2 years 0.9 vs. 0.0 [42]
STOPDAPT

Xience

(n = 1522)

1 year 0 [43]
TWENTE

Endeavor Resolute vs Xience

(n = 1391)

1 year

0.58% and 0%

(p = 0.12)

[44]